Technical Analysis for CSTL - Castle Biosciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Historical CSTL trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
Multiple of Ten Bullish | Other | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Hammer Candlestick | Bullish | -6.59% | |
Lizard Bullish | Bullish Day Trade Setup | -6.59% | |
Doji - Bullish? | Reversal | -6.59% | |
Down 3 Days in a Row | Weakness | -6.59% | |
Down 4 Days in a Row | Weakness | -6.59% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Down 1 ATR | about 14 hours ago |
Down 5% | about 15 hours ago |
Fell Below Previous Day's Low | about 15 hours ago |
60 Minute Opening Range Breakdown | about 15 hours ago |
Down 3% | about 15 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/09/2020
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The company offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Clinical Medicine Melanoma Medical Tests Gene Expression Metastasis Dsw
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Clinical Medicine Melanoma Medical Tests Gene Expression Metastasis Dsw
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 107.69 |
52 Week Low | 26.13 |
Average Volume | 316,599 |
200-Day Moving Average | 58.58 |
50-Day Moving Average | 73.07 |
20-Day Moving Average | 66.60 |
10-Day Moving Average | 67.47 |
Average True Range | 4.35 |
ADX | 16.24 |
+DI | 19.12 |
-DI | 32.84 |
Chandelier Exit (Long, 3 ATRs ) | 62.88 |
Chandelier Exit (Short, 3 ATRs ) | 69.79 |
Upper Bollinger Band | 75.43 |
Lower Bollinger Band | 57.77 |
Percent B (%b) | 0.16 |
BandWidth | 26.52 |
MACD Line | -1.31 |
MACD Signal Line | -0.98 |
MACD Histogram | -0.3338 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 69.14 | ||||
Resistance 3 (R3) | 69.50 | 67.04 | 67.72 | ||
Resistance 2 (R2) | 67.04 | 64.88 | 66.86 | 67.25 | |
Resistance 1 (R1) | 63.85 | 63.55 | 62.62 | 63.49 | 66.78 |
Pivot Point | 61.39 | 61.39 | 60.78 | 61.21 | 61.39 |
Support 1 (S1) | 58.20 | 59.23 | 56.97 | 57.84 | 54.54 |
Support 2 (S2) | 55.74 | 57.90 | 55.56 | 54.07 | |
Support 3 (S3) | 52.55 | 55.74 | 53.60 | ||
Support 4 (S4) | 52.19 |